Search results for "Highlights"
ACG guideline updates recommendations on diagnosis, management of GERD
Proton-pump inhibitors remain a standard treatment for gastroesophageal reflux disease (GERD) despite increased scrutiny of side effects, although new treatments are emerging, the guideline from the American College of Gastroenterology (ACG) stated.
https://gastroenterology.acponline.org/archives/2021/12/17/1.htm
17 Dec 2021
Q&A: A deeper dive into ACP's new diverticulitis guidelines
Authors discussed the College's first clinical guidelines on diagnosis and management of diverticulitis, which provide recommendations on when to use imaging, antibiotics, colonoscopy, and other interventions.
https://gastroenterology.acponline.org/archives/2022/01/28/1.htm
28 Jan 2022
Prevalence of liver fibrosis in diabetes suggests need for earlier intervention, study finds
The prevalence of any suspected liver fibrosis in patients with diabetes was 21% in a recent study, leading the authors to call for more aggressive screening in patients with obesity and diabetes.
https://gastroenterology.acponline.org/archives/2021/01/22/3.htm
22 Jan 2021
Best practice advice offered for diagnosis, management of seronegative enteropathy
The American Gastroenterological Association said that diagnosis of seronegative celiac disease, the most common cause of seronegative enteropathy, can be complicated by misinterpretation of histological findings, insufficient serological testing, IgA deficiency, and premature initiation of a gluten-free diet.
https://gastroenterology.acponline.org/archives/2020/10/23/3.htm
23 Oct 2020
Tenofovir alafenamide may safely replace tenofovir disoproxil fumarate in patients with drug-resistant HBV, trial finds
An industry-funded randomized trial found that tenofovir alafenamide could be substituted for tenofovir disoproxil fumarate in patients with multidrug-resistant hepatitis B virus (HBV) for improved bone and renal safety without a loss of efficacy; however, the former drug was associated with greater increases in body weight and cholesterol levels.
https://gastroenterology.acponline.org/archives/2021/05/28/4.htm
28 May 2021
Model that blends machine learning, traditional risk score may improve cirrhosis prediction
Using clinical variables identified from simple machine learning in a cirrhosis mortality model produced a new score that was more transparent than a commonly used version of the Model for End-Stage Liver Disease, a study found.
https://gastroenterology.acponline.org/archives/2020/11/20/3.htm
20 Nov 2020
CDC updates guidance on responding to health care exposures to HCV
The CDC called for hepatitis C virus (HCV) testing of both the patient and exposed personnel as soon as possible after an exposure incident, preferably within 48 hours.
https://gastroenterology.acponline.org/archives/2020/08/28/2.htm
28 Aug 2020
AASLD offers guidance on reproductive health and liver disease
Menopausal hormone therapy should not be used in women with decompensated liver function, Budd-Chiari syndrome, or hepatocellular adenomas, the American Association for the Study of Liver Diseases (AASLD) said, among other recommendations.
https://gastroenterology.acponline.org/archives/2020/09/25/2.htm
25 Sep 2020
Wireless monitoring identified patients who could discontinue PPIs
Patients with reflux symptoms and inadequate response to proton-pump inhibitors (PPIs) discontinued the drugs for a week and then had their acid exposure time measured by a wireless pH capsule in a recent study.
https://gastroenterology.acponline.org/archives/2020/09/25/3.htm
25 Sep 2020
Treatment algorithm updated for chronic HBV
The recommendations address use of newer therapies and are intended to offer guidance on treating chronic hepatitis B virus (HBV) infection while additional antiviral agents are in development.
https://gastroenterology.acponline.org/archives/2021/08/27/1.htm
27 Aug 2021